Your browser doesn't support javascript.
loading
Efficacy and Safety of a Proposed Ranibizumab Biosimilar Product vs a Reference Ranibizumab Product for Patients With Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial.
Woo, Se Joon; Veith, Miroslav; Hamouz, Jan; Ernest, Jan; Zalewski, Dominik; Studnicka, Jan; Vajas, Attila; Papp, Andras; Gabor, Vogt; Luu, James; Matuskova, Veronika; Yoon, Young Hee; Pregun, Tamás; Kim, Taehyung; Shin, Donghoon; Bressler, Neil M.
Afiliación
  • Woo SJ; Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
  • Veith M; Department of Ophthalmology, Third Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
  • Hamouz J; Department of Ophthalmology, University Hospital Kralovske Vinohrady, Prague, Czech Republic.
  • Ernest J; Department of Ophthalmology, Third Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
  • Zalewski D; Department of Ophthalmology, University Hospital Kralovske Vinohrady, Prague, Czech Republic.
  • Studnicka J; Department of Ophthalmology, Central Military Hospital, Prague, Czech Republic.
  • Vajas A; Diagnostic and Microsurgery Center of the Eye LENS, Olsztyn, Poland.
  • Papp A; Department of Ophthalmology, Faculty of Medicine in Hradec Kralove, Charles University in Prague, Prague, Czech Republic.
  • Gabor V; Department of Ophthalmology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
  • Luu J; Department of Ophthalmology, University of Debrecen, Debrecen, Hungary.
  • Matuskova V; Department of Ophthalmology, Semmelweis University, Budapest, Hungary.
  • Yoon YH; Department of Ophthalmology, Medical Centre, Hungarian Defence Forces, Budapest, Hungary.
  • Pregun T; Retina Consultants of Southern Colorado, Colorado Springs.
  • Kim T; Department of Ophthalmology, University Hospital Brno, Brno, Czech Republic.
  • Shin D; Faculty of Medicine Masaryk University, Brno, Czech Republic.
  • Bressler NM; Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
JAMA Ophthalmol ; 139(1): 68-76, 2021 01 01.
Article en En | MEDLINE | ID: mdl-33211076

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Visión Ocular / Neovascularización Coroidal / Inhibidores de la Angiogénesis / Factor A de Crecimiento Endotelial Vascular / Biosimilares Farmacéuticos / Ranibizumab / Degeneración Macular Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Ophthalmol Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Visión Ocular / Neovascularización Coroidal / Inhibidores de la Angiogénesis / Factor A de Crecimiento Endotelial Vascular / Biosimilares Farmacéuticos / Ranibizumab / Degeneración Macular Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Ophthalmol Año: 2021 Tipo del documento: Article